Studies assessing the correlation between soluble SDC1 in plasma and clinical outcome in patients with chronic lymphocytic leukemia have shown that soluble SDC1 levels were significantly higher in these patients compared to healthy control subjects. The gene discussed is SDC1; the disease is B-cell chronic lymphocytic leukemia.